These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9303339)

  • 1. Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma.
    Oosaki R; Mizushima Y; Kashii T; Kawasaki A; Kobayashi M
    Int Arch Allergy Immunol; 1997 Sep; 114(1):97-100. PubMed ID: 9303339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H; Sugita A; Azuma M; Ogawa H; Kitamuro C; Yoneda K; Shinkawa K; Tani K; Sone S
    Lung; 2004; 182(1):51-8. PubMed ID: 14752672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma.
    Kohrogi H; Iwagoe H; Fujii K; Hamamoto J; Fukuda K; Hirata N; Kawano O; Matsumoto M; Suga M; Ando M
    Respirology; 1999 Sep; 4(3):319-23. PubMed ID: 10489683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
    Tomita K; Hashimoto K; Matsumoto S; Nakamoto N; Tokuyasu H; Yamasaki A; Yajima H; Sasaki T; Kawasaki Y; Fukutani K
    Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.
    Asano K; Shiomi T; Hasegawa N; Nakamura H; Kudo H; Matsuzaki T; Hakuno H; Fukunaga K; Suzuki Y; Kanazawa M; Yamaguchi K
    Pharmacogenetics; 2002 Oct; 12(7):565-70. PubMed ID: 12360108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Nakata J; Takemura H; Nagai A; Takizawa T; Konno K
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1235-40. PubMed ID: 9105060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Ito T
    Arzneimittelforschung; 2003; 53(10):714-21. PubMed ID: 14650364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics.
    Yamauchi K; Tanifuji Y; Pan LH; Yoshida T; Sakurai S; Goto S; Kuroda S; Kobayashi H; Inoue H
    J Asthma; 2001 Feb; 38(1):51-7. PubMed ID: 11256554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.